Sg3 Management, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $311,898 - $504,394	-45,400 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$7.7 - $37.13 $225,610 - $1.09 Million	29,300 Added 181.99%	45,400 $444,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $426,006 - $598,115	16,100 New	16,100 $547,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $1.08 Million - $1.58 Million	-33,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $121,170 - $170,190	3,000 Added 10.0%	33,000 $1.48 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $1.55 Million - $1.99 Million	-30,000 Reduced 50.0%	30,000 $1.71 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $2.63 Million - $3.49 Million	60,000 New	60,000 $3.08 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.